Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN® Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ischemic Stroke
- Sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Enrollment
- 90
- Locations
- 1
- Primary Endpoint
- Dynamics of rehabilitation routing status score
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
Post intensive care syndrome (PIC syndrome) is an important problem in modern intensive care strategy. Understanding the mechanisms of PIC syndrome helps prevent it in patients with respiratory, neuromuscular transmission, and cognitive impairments that require prolonged support of vital functions. Significant role in the formation and severity of PIC syndrome is played by the severity of the systemic inflammatory response, which is an individual reaction of the body, and this determines the degree of neurological and psychological deficits. Chronic diseases such as diabetes mellitus, especially in the context of metabolic syndrome, worsen the course of PIC syndrome and delays recovery. Early initiation of rehabilitation measures in the intensive care unit and subsequent expansion of the individual rehabilitation program contributes to the rapid and successful recovery of not only vital functions, but also cognitive, motor and emotional disorders. This shortens the hospital stay of patient and improves their quality of life after discharge.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men and women over 18 years of age and older;
- •Stay in the ITU and (or) intensive care unit for at least 3 days;
- •Diagnosed "post intensive care" syndrome (PIC syndrome) with moderate-to-severe severity \>3\<6 points
- •Diagnosed modalities "critical illness polyneuropathy, respiratory neuropathy, dysphagia" of the domain "Neuromuscular complications" of PIC syndrome at 2-3 stages of the rehabilitation route at any value of PICS severity index
- •Diagnosed modalities "decreased gravitational gradient, decreased exercise tolerance" in the domain "Vegetative-metabolic complications" at 2-3 stages of the rehabilitation route at any value of PICS severity index
Exclusion Criteria
- •Premorbid level of vital activity when assessed on the rehabilitation routing scale 4-5 points;
- •Hematocrit ≤30%;
- •Hemoglobin level ≤80 g/L;
- •Acute cardiac failure;
- •Acute respiratory failure;
- •Acute renal failure;
- •Acute liver cell failure;
- •Use of drugs from "metabolic agents" pharmacotherapeutic group at the time of inclusion in the study
- •Life expectancy of 6 months or less or presence of incurable diseases in decompensation stage
Outcomes
Primary Outcomes
Dynamics of rehabilitation routing status score
Time Frame: day 12, day 30, day 60, day 90
Dynamics of rehabilitation routing status score from the start of the study (Visit 1) to Visit 3, Visit 4, Visit 5 and Visit 6 measured in both groups
Dynamics of Barthel status score
Time Frame: day 12, day 30, day 60, day 90
Dynamics of Barthel status score from the start of the study (Visit 1) to Visit 3, Visit 4, Visit 5 and Visit 6 measured in both groups
Dynamics of EQ5 status score
Time Frame: day 12, day 30, day 60, day 90
Dynamics of EQ5 status score from the start of the study (Visit 1) to Visit 3, Visit 4, Visit 5 and Visit 6 measured in both groups
Secondary Outcomes
- Dynamics of somatic status(day 12, day 30, day 60, day 90)
- Dynamics of rehabilitation status(day 12, day 30, day 60, day 90)